BET bromodomain inhibition as a novel strategy for reactivation of HIV-1

The persistence of latent HIV-1 remains a major challenge in therapeutic efforts to eradicate infection. We report the capacity for HIV reactivation by a selective small molecule inhibitor of BET family bromodomains, JQ1, a promising therapeutic agent with antioncogenic properties. JQ1 reactivated H...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Banerjee, Camellia, Archin, Nancie, Michaels, Daniel, Belkina, Anna C., Denis, Gerald V., Bradner, James, Sebastiani, Paola, Margolis, David M., Montano, Monty
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society for Leukocyte Biology 2012
Gaiak:
Spotlight on Leading Edge Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3501896/
https://ncbi.nlm.nih.gov/pubmed/22802445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.0312165
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak